<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7</volume><submitter>Lightfoot M</submitter><pubmed_abstract>Purpose: Endoscopic dextranomer/hyaluronic acid (Dx/HA) injection is a common treatment for vesicoureteral reflux (VUR) with excellent reported short-term clinical success rates. Long-term outcomes are less well-defined. We assessed long-term outcomes and parental satisfaction after Dx/HA injection for primary VUR with >5-year follow-up. Materials and Methods: Families of all patients who underwent Dx/HA injection for primary VUR at our institution between 2008 and 2012 were contacted for telephone interview. Data collected by phone included parental satisfaction and presence and severity of UTIs pre-operatively and post-operatively. Patient demographics, radiographic VUR data, need for secondary surgery, and surgical indications were obtained through chart review. Results: Five hundred an</pubmed_abstract><journal>Frontiers in pediatrics</journal><pagination>392</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6776605</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux.</pubmed_title><pmcid>PMC6776605</pmcid><pubmed_authors>Bilgutay AN</pubmed_authors><pubmed_authors>Weiser J</pubmed_authors><pubmed_authors>Elmore J</pubmed_authors><pubmed_authors>Eisenberg S</pubmed_authors><pubmed_authors>Bryan L</pubmed_authors><pubmed_authors>Lightfoot M</pubmed_authors><pubmed_authors>Scherz H</pubmed_authors><pubmed_authors>Tollin N</pubmed_authors><pubmed_authors>Smith E</pubmed_authors><pubmed_authors>Kirsch AJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-Term Clinical Outcomes and Parental Satisfaction After Dextranomer/Hyaluronic Acid (Dx/HA) Injection for Primary Vesicoureteral Reflux.</name><description>Purpose: Endoscopic dextranomer/hyaluronic acid (Dx/HA) injection is a common treatment for vesicoureteral reflux (VUR) with excellent reported short-term clinical success rates. Long-term outcomes are less well-defined. We assessed long-term outcomes and parental satisfaction after Dx/HA injection for primary VUR with >5-year follow-up. Materials and Methods: Families of all patients who underwent Dx/HA injection for primary VUR at our institution between 2008 and 2012 were contacted for telephone interview. Data collected by phone included parental satisfaction and presence and severity of UTIs pre-operatively and post-operatively. Patient demographics, radiographic VUR data, need for secondary surgery, and surgical indications were obtained through chart review. Results: Five hundred an</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-04-04T08:29:52.819Z</modification><creation>2019-10-18T07:02:58Z</creation></dates><accession>S-EPMC6776605</accession><cross_references><pubmed>31612121</pubmed><doi>10.3389/fped.2019.00392</doi></cross_references></HashMap>